SCHEMBL1265022

SCHEMBL1265022

OCCCCCCCCCCCCc1ccccc1I

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.52
IDO1 P14902 2/20 0.41
LIPG Q9Y5X9 1/20 0.40
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
MGLL Q99685 1/20 0.36
BCHE P06276 1/20 0.35
CA2 P00918 1/20 0.34
BID P55957 1/20 0.34
BCL2L1 Q07817 1/20 0.34
MCL1 Q07820 1/20 0.34
BAK1 Q16611 1/20 0.34
KCNH3 Q9ULD8 1/20 0.34
TBXAS1 P24557 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2313037 1.00 TAAR1 (0.52) TAAR1IDO1LIPGCYP1A2CYP2D6
SCHEMBL19429813 1.00 TAAR1 (0.52) TAAR1IDO1LIPGCYP1A2CYP2D6
SCHEMBL2308344 0.98 TAAR1 (0.54) TAAR1IDO1LIPGCYP1A2CYP2D6
SCHEMBL30240126 0.91 TAAR1 (0.56) TAAR1IDO1LIPGCYP1A2CYP2D6
SCHEMBL2185670 0.91 TAAR1 (0.56) TAAR1IDO1LIPGCYP1A2CYP2D6
SCHEMBL2178352 0.84 LIPG (0.47) LIPGMGLLBCHECA2BID
SCHEMBL30813041 0.82 TAAR1 (0.60) TAAR1IDO1CYP1A2CYP2D6CYP2C9
SCHEMBL3164443 0.82 TAAR1 (0.60) TAAR1IDO1CYP1A2CYP2D6CYP2C9
SCHEMBL30750761 0.82 LIPG (0.43) TAAR1LIPGMGLLBCHECA2
SCHEMBL9672220 0.82 LIPG (0.43) TAAR1LIPGMGLLBCHECA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022235-B2 Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use CELLECTAR, INC. (US) 2011-09-20 US disclosed
US-7893286-B2 Method for the synthesis of phospholipid ethers CELLECTAR, INC. (US) 2011-02-22 US disclosed
US-20090018357-A1 Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use CELL ACQUISITION CORP. 2009-01-15 US disclosed
US-20080312459-A1 Method for the synthesis of phospholipid ethers CELL ACQUISITION CORP. 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018357-A1 Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use PHOSPHO1, PEBP1, SGMS1 TAAR1 2583/4885IDO1 4806/4885LIPG 248/4885
US-20080312459-A1 Method for the synthesis of phospholipid ethers PHOSPHO1, PLEC, PLA2G2C TAAR1 1768/4885IDO1 2616/4885LIPG 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.